PROTEIN ANALYSIS OF EXOSOMES

Ilva Nakurte1, Kaspars Jekabsons1, Una Riekstina1, Arturs Abols2, Liga Saulite1, Matiss Otersbergs1, Aija Line2, Ruta Muceniece1

1 University of Latvia, Faculty of Medicine, Raina blvd. 19, Riga, LV – 1586, Latvia

2 Latvian Biomedical Research and Study Centre, Ratsupites Str. 1, Riga, LV-1067, Latvia

Exosomes are small cup-shaped vesicles of endosomal origin that are released in the extracellular space by a variety of normal cell types, including epithelial cells, mesenchymal stem cells, dendritic cells, T and B cells, and various cancers, and have been found in all human body fluids [1]. They have been shown to carry a variety of lipids, proteins, mRNAs and non-coding RNAs that can be taken up by recipient cells, where they trigger intracellular signalling resulting in diverse physiological and pathological responses [2]. This suggests that exosomes mediate a widespread mode of intercellular communication exploited by a variety of normal cells and hijacked by cancers. However, the mechanisms by which various components are sorted for loading into exosomes, as well as the factors determining recipient cell specificity and the mechanisms of exosome uptake are poorly understood.

The recent advances in mass spectrometry-based proteomics have facilitated the comprehensive analysis of exosome content and function. Proteomic analysis has revealed that exosomes contain a common set of membrane and cytosolic proteins, and they also contain distinct subsets of proteins that could be associated with cell type-specific functions [3].

The aim of this study was to characterize the biochemical profile and proteome of hypoxia and normoxia grown exosomes derived from human primary (SW480) and metastatic (SW620) colorectal cancer cells.

Peptide libraries of exosomes were obtained using XPEP1000A-1 reagent kit (SBBS Systems Biosciences, Canada). The kit comes complete to create either exosome surface protein “shaving” peptide libraries or complete exosome peptide library preparation. Totally eight different peptide libraries were obtained. Protein content was measured with the reagent kit - BCA protein assay kit No.23227 (Pierce Biotechnology, USA).

Chromatographic analyses were performed on a modular UPLC system, Agilent 1290 Infinity series. Liquid chromatography separations were achieved by using an Extend-C18 RRHD column (2.1x50 mm, 1.8µm). Elution solvents consist of 0.1% formic acid in acetonitrile and 0.1% formic acid in water in gradient mode at a flow rate of 0.3 mL/min. The high resolution mass spectra were taken on an Agilent 6230 TOF LC/MS with electrospray ionization in positive mode. Mass spectra were collected over an m/z range of 300-2500 Da.

The differences between all protein fractions were observed. Surface protein concentration in SW620 cells was 1.6 times higher extracted from hypoxia exosomes, compared with normoxia. The concentration ratio in SW480 cells was 1.78 respectively. Differences between content of total proteins extracted from hypoxia and normoxia grown exosome were less significant. First liquid chromatography-masspectrometry data shown differences between all eight chromatograms obtained from protein libraries. Differences between hypoxia and normoxia grown exosomes were observed as well.

Based on the obtained results we can conclude that the total content of proteins and protein profile varies depending on hypoxia and normoxia. Hypoxia increases the proteome. Liquid chromatography - masspectrometry method can be applied to characterise the biochemical profile and proteome of exosomes derived from various cell types in order to identify specific biochemically measurable parameters and proteins that can be used to discriminate cancer-derived exosomes form those released by normal tissues and to reveal the hypoxia-regulated exosomal components.

Acknowledgments: The work has been supported by Latvian Council of Science grant Nr. 625/2014.


[1] S. Pant, H. Hilton H, M.E. Burczynski et al.,. The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol.83, 1484-1494 (2012).

[2] A.S. Azmi, B. Bao, F.H. Sarkar et al., Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev.32, 623-642 (2013).

[3] S.N. Thomas, Z. Liao et al., Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer. Proteomes1, 87-108 (2013).